Start-up

PharmAI GmbH

About PharmAI

Our disruptive software technology identifies drug candidates based on the geometry of protein binding sites and their drug-target interactions, paving new ways to explore the drug-target space at a ground-breaking level of precision.

Product portfolio of PharmAI

Product portfolio

Show all

Continuous Low‑pH Virus Inactivation for Integrated Bioprocessing

Advanced TFF Technology for Enhanced Monoclonal Antibody Concentration and Processing

Industry-optimized ERP for the life sciences industry

News about PharmAI

07-Oct-2022 | research and development

As easy as Googling - AI finds the right substances

Chemspace and PharmAI collaborate to make the world's largest online catalog of small molecules and biologics even more user-friendly

Read news

12-Apr-2022 | research and development

A free AI tool to quickly determine which protein labeling strategy works best for molecular interaction measurements

NanoTemper Technologies and PharmAI launch Proto

Read news

25-Mar-2021 | business & finance

NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets. P ...

Read news